Skip to content
Annika Bansal – Lifestyle
Author:
Immunocore Holdings plc
Immunocore reports second quarter financial results and provides a business update
August 6, 2026
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
July 30, 2026
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
May 31, 2026
Bristow Group Reports First Quarter 2026 Results
May 7, 2026
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
April 19, 2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
April 6, 2026
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
March 17, 2026
Immunocore to present at upcoming investor conferences
March 5, 2026